← Open Payments lookup

JOEL MORCILLA: Open Payments

NPI 1942832191 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 27 payments from 13 companies in 2025. Trend: 2023 $442 · 2024 $401 · 2025 $639

Food & beverage: $639
CompanyPaymentsAmount
Amgen Inc.7$203
Lilly USA, LLC3$71
Sumitomo Pharma America, Inc.3$69
AstraZeneca Pharmaceuticals LP3$54
Exact Sciences Corporation2$53
Astellas Pharma US Inc2$44
Boehringer Ingelheim Pharmaceuticals, Inc.1$28
E.R. Squibb & Sons, L.L.C.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Avvisto Therapeutics, LLC1$19

Products named: REPATHA, GEMTESA, OTEZLA, Cologuard Collection Kit, JARDIANCE, MOUNJARO, Veozah, FARXIGA.

Industry payments across TX — which companies pay providers there.